Closed
The Marked Chart Wire · Business
Palantir
Palantir posted $2.3 billion in sales for the third quarter, marking a 96 percent jump from the prior-year period.
Part of a series: Palantir earnings beat and guidance raise follow analyst debate
Prices from Before the open · based on Mon close · Opens 9:30 AM ET. Each tile opens the stock's chart and news.
New to this? Read: Reading a stock chart
Palantir
Palantir Technologies reported third-quarter revenue of $2.31 billion, above the $2.17 billion estimate, with net income of $1.13 billion. The company also raised its full-year revenue guidance to $8.53 billion from $8.21 billion.
Palantir
Palantir reports third-quarter results on Monday, with analysts expecting earnings of 41 cents per share and revenue of $2.18 billion. Shares fell 6.3 percent as forecasters adjusted their views ahead of the release.
Palantir
Palantir reported that U.S. commercial revenue rose 149 percent last quarter as both government and commercial divisions continue to expand.
Merck
Merck has agreed to exit its US contract development and manufacturing organization business by selling the division to Lonza.
Philips
Koninklijke Philips reported a sharp drop in third-quarter profit due to a Respironics settlement provision, while adjusted EBITDA increased on higher sales. The company maintained its full-year 2026 outlook.
BioMarin
BioMarin projects full-year 2026 revenue between $3.8 billion and $3.9 billion. The company also noted $70 million in order deferrals.
Fast headlines, summarized. Not verified and not advice. Check the full story before you act.